Nomogram to predict the benefit of radiation for older patients with breast cancer treated with conservative surgery

Journal of Clinical Oncology

Volumn 30, Issue 23, 2012, Pages 2837-2843

  Albert, Jeffrey M ^a   Liu, Diane D ^a   Shen, Yu ^a   Pan, I Wen ^b   Shih, Ya Chen Tina ^b   Hoffman, Karen E ^a   Buchholz, Thomas A ^a   Giordano, Sharon H ^a   Smith, Benjamin D ^a  

^a UNIVERSITY OF TEXAS   (United States)

^b UNIVERSITY OF CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ESTROGEN RECEPTOR;

ACCURACY; AGED; ARTICLE; BREAST CANCER; CANCER RADIOTHERAPY; CANCER REGISTRY; CANCER SIZE; CANCER SURGERY; CANCER SURVIVAL; CONSERVATIVE TREATMENT; FEMALE; FOLLOW UP; HUMAN; INTERNAL VALIDITY; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MASTECTOMY; MEDICARE; MULTIMODALITY CANCER THERAPY; NOMOGRAM; OVERALL SURVIVAL; PREDICTIVE VALUE; PRIORITY JOURNAL; RACE; RISK BENEFIT ANALYSIS;

AGED; BREAST NEOPLASMS; FEMALE; HUMANS; MASTECTOMY, SEGMENTAL; NOMOGRAMS; SEER PROGRAM;

EID: 84865082417     PISSN: 0732183X     EISSN: 15277755     Source Type: Journal    
DOI: 10.1200/JCO.2011.41.0076     Document Type: Article

References (37)

1. Howlader N, Noone AM, Krapcho M, et al: SEER Cancer Statistics Review, 1975-2008. Bethesda, MD, National Cancer Institute, 2011
2. Clarke M, Collins R, Darby S, et al: Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: An overview of the randomised trials. Lancet 366:2087-2106, 2005
3. Liljegren G, Holmberg L, Bergh J, et al: 10-Year results after sector resection with or without postoperative radiotherapy for stage I breast cancer: A randomized trial. J Clin Oncol 17:2326-2333, 1999 (Pubitemid 29368230)
4. Veronesi U, Marubini E, Mariani L, et al: Radiotherapy after breast-conserving surgery in small breast carcinoma: Long-term results of a randomized trial. Ann Oncol 12:997-1003, 2001 (Pubitemid 32725776)
5. Fyles AW, McCready DR, Manchul LA, et al: Tamoxifen with or without breast irradiation in women 50 years of age or older with early breast cancer. N Engl J Med 351:963-970, 2004
6. Hughes KS, Schnaper LA, Berry D, et al: Lumpectomy plus tamoxifen with or without irradiation in women 70 years of age or older with early breast cancer. N Engl J Med 351:971-977, 2004 (Pubitemid 39166260)
7. Hughes KS, Schnaper LA, Cirrincione C, et al: Lumpectomy plus tamoxifen with or without irradiation in women age 70 or older with early breast cancer. J Clin Oncol 28:69s, 2010 (suppl; abstr 507)
8. Pötter R, Gnant M, Kwasny W, et al: Lumpectomy plus tamoxifen or anastrozole with or without whole breast irradiation in women with favorable early breast cancer. Int J Radiat Oncol Biol Phys 68:334-340, 2007
9. National Comprehensive Cancer Network: NCCN Clinical Practice Guidelines in Oncology: Breast Cancer (Version 2.2011). Fort Washington, PA, National Comprehensive Cancer Network, 2011
10. Britton A, McKee M, Black N, et al: Threats to applicability of randomised trials: Exclusions and selective participation. J Health Serv Res Policy 4:112-121, 1999 (Pubitemid 29186862)
11. Gross CP, Mallory R, Heiat A, et al: Reporting the recruitment process in clinical trials: Who are these patients and how did they get there? Ann Intern Med 137:10-16, 2002 (Pubitemid 34705371)
12. Murthy VH, Krumholz HM, Gross CP: Participation in cancer clinical trials: Race-, sex-, and age-based disparities. JAMA 291:2720-2726, 2004 (Pubitemid 38725421)
13. Lash TL, Fox MP, Westrup JL, et al: Adherence to tamoxifen over the five-year course. Breast Cancer Res Treat 99:215-220, 2006 (Pubitemid 44268270)
14. Owusu C, Buist DS, Field TS, et al: Predictors of tamoxifen discontinuation among older women with estrogen receptor-positive breast cancer. J Clin Oncol 26:549-555, 2008 (Pubitemid 351264347)
15. Partridge AH, Wang PS, Winer EP, et al: Nonadherence to adjuvant tamoxifen therapy in women with primary breast cancer. J Clin Oncol 21:602-606, 2003 (Pubitemid 46621892)
16. Ziller V, Kalder M, Albert US, et al: Adherence to adjuvant endocrine therapy in postmenopausal women with breast cancer. Ann Oncol 20:431-436, 2009
17. White J, Morrow M, Moughan J, et al: Compliance with breast-conservation standards for patients with early-stage breast carcinoma. Cancer 97:893-904, 2003 (Pubitemid 36173140)
18. Smith BD, Gross CP, Smith GL, et al: Effectiveness of radiation therapy for older women with early breast cancer. J Natl Cancer Inst 98:681-690, 2006 (Pubitemid 43821786)
19. Gandhi S, Verma S: Early breast cancer in the older woman. Oncologist 16:479-485, 2011
20. Kunkler IH, Williams LJ, King CC, et al: Breast radiotherapy: Considerations in older patients. Clin Oncol (R Coll Radiol) 21:111-117, 2009
21. Hayman JA, Hillner BE, Harris JR, et al: Cost-effectiveness of routine radiation therapy following conservative surgery for early-stage breast cancer. J Clin Oncol 16:1022-1029, 1998 (Pubitemid 28108736)
22. Smith BD, Smith GL, Hurria A, et al: Future of cancer incidence in the United States: Burdens upon an aging, changing nation. J Clin Oncol 27:2758-2765, 2009
23. Iasonos A, Schrag D, Raj GV, et al: How to build and interpret a nomogram for cancer prognosis. J Clin Oncol 26:1364-1370, 2008
24. International Bladder Cancer Nomogram Consortium, Bochner BH, Kattan MW, et al: Postoperative nomogram predicting risk of recurrence after radical cystectomy for bladder cancer. J Clin Oncol 24:3967-3972, 2006
25. Brennan MF, Kattan MW, Klimstra D, et al: Prognostic nomogram for patients undergoing resection for adenocarcinoma of the pancreas. Ann Surg 240:293-298, 2004 (Pubitemid 38963021)
26. Rudloff U, Jacks LM, Goldberg JI, et al: Nomogram for predicting the risk of local recurrence after breast-conserving surgery for ductal carcinoma in situ. J Clin Oncol 28:3762-3769, 2010
27. Stephenson AJ, Scardino PT, Eastham JA, et al: Postoperative nomogram predicting the 10-year probability of prostate cancer recurrence after radical prostatectomy. J Clin Oncol 23:7005-7012, 2005
28. Van Zee KJ, Manasseh DM, Bevilacqua JL, et al: A nomogram for predicting the likelihood of additional nodal metastases in breast cancer patients with a positive sentinel node biopsy. Ann Surg Oncol 10:1140-1151, 2003 (Pubitemid 40486808)
29. Weiser MR, Landmann RG, Kattan MW, et al: Individualized prediction of colon cancer recurrence using a nomogram. J Clin Oncol 26:380-385, 2008 (Pubitemid 351171688)
30. Rockhill B, Spiegelman D, Byrne C, et al: Validation of the Gail et al. model of breast cancer risk prediction and implications for chemoprevention. J Natl Cancer Inst 93:358-366, 2001 (Pubitemid 32229380)
31. Goldstein LJ, Gray R, Badve S, et al: Prognostic utility of the 21-gene assay in hormone receptor-positive operable breast cancer compared with classical clinicopathologic features. J Clin Oncol 26:4063-4071, 2008
32. Early Breast Cancer Trialists' Collaborative Group: Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: An overview of the randomised trials. Lancet 365:1687-1717, 2005
33. Fisher B, Bryant J, Dignam JJ, et al: Tamoxifen, radiation therapy, or both for prevention of ipsilateral breast tumor recurrence after lumpectomy in women with invasive breast cancers of one centimeter or less. J Clin Oncol 20:4141-4149, 2002 (Pubitemid 35191016)
34. Nekhlyudov L, Li L, Ross-Degnan D, et al: Five-year patterns of adjuvant hormonal therapy use, persistence, and adherence among insured women with early-stage breast cancer. Breast Cancer Res Treat 130:681-689, 2011
35. Lin JH, Zhang SM, Manson JE: Predicting adherence to tamoxifen for breast cancer adjuvant therapy and prevention. Cancer Prev Res (Phila) 4:1360-1365, 2011
36. Fink AK, Gurwitz J, Rakowski W, et al: Patient beliefs and tamoxifen discontinuance in older women with estrogen receptor-positive breast cancer. J Clin Oncol 22:3309-3315, 2004 (Pubitemid 41103687)
37. Kimmick G, Anderson R, Camacho F, et al: Adjuvant hormonal therapy use among insured, low-income women with breast cancer. J Clin Oncol 27:3445-3451, 2009